Dilon Devices Announced Today that a U.S. Food and Drug Administration (FDA) Advisory Panel Voted (10 to 1) in favor of Dune’s MarginProbe® System

[vc_row][vc_column][vc_column_text]FDA Advisory Panel Votes in Favor of Dilon Devices MarginProbe® System Gaithersburg, MD, June 22, 2012 – Dilon Devices announced today that a U.S. Food and Drug Administration (FDA) Advisory Panel voted (10 to 1) in favor of Dune’s MarginProbe System for use in breast cancer surgery, as an adjunct to current standard methods of…

Read More